Consuming a more anti-inflammatory diet may modulate systemic and metabolic inflammation, potentially reducing gout risk and its life-threatening comorbidities, particularly for women, who are ...

Gout Gout is challenging some conventional sprinting paradigms – namely that raw power and muscle mass are the primary determinants of speed.

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma ...

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a ...

The 2025 Continental Tour Maurie Plant Meet will feature some of the biggest up-and-coming names in the track and field world ...

Crawling into bed to rest her painful left toe, Mel Gardener winced as she covered herself with a cotton sheet. Even the touch of this light fabric was excruciating.

Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...

If you've ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of arthritis is often associated with sharp, sudden pain in the big toe, gout ...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...

? REDUCE 1 is a study running in parallel with REDUCE 2 to evaluate AR882's efficacy in lowering serum urate (sUA) levels in gout patients ? SAN DIEGO, March 17, 2025 /PRNewswire/ -- Arthrosi ...